BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Drug Development

  SCYNEXIS Presents New In Vivo Data Highlighting the Potential of SCY-078 Used in Combination for the Treatment of Aspergillus Infections at AAA 2018

  These results further confirm in vitro data that demonstrated the synergistic and additive activity of SCY-078 in combination with ISA against Aspergillus spp.

  February 1, 2018

   · 

  5 min read
• Biotech Beach

  Simulations Plus Launches Version 2.0 of PKPlus

  Simulations Plus today announced the launch of version 2.0 of PKPlus, a major update to its software for analysis of preclinical and clinical trial data.

  February 1, 2018

   · 

  3 min read
• Pharm Country

  Amneal Introduces Isotretinoin Capsules, USP

  Amneal has launched isotretinoin capsules, USP, an AB-rated generic for Accutane in 10 mg, 20 mg, 30 mg and 40 mg strengths.

  February 1, 2018

   · 

  1 min read
• Business

  Chrono Therapeutics Announces Appointment of David Happel as CEO

  Chrono Therapeutics, a pioneer in digital drug therapy, today announced that Alan Levy Ph.D., CEO and chairman of the board of directors is retiring.

  February 1, 2018

   · 

  2 min read
• Business

  Dynatronics Welcomes Skyler Black as Its New Corporate Controller, Further Strengthens Its Finance Team

  Dynatronics Corporation today announced the appointment of Skyler Black as Corporate Controller, effective January 22, 2018.

  February 1, 2018

   · 

  2 min read
• 

  Business

  Voyager Founder and CEO to Step Down, Hunt for New Leader Begins

  Dr. Paul has been with the company for six years since its inception, initially as president of R&D,

  February 1, 2018

   · 

  6 min read
• Pharm Country

  Delcath Announces Satisfaction of 2016 Convertible Note

  On December 28, 2017, Delcath entered into exchange agreements with two institutional investors pursuant to which those investors were issued, in exchange for satisfaction in full of those notes.

  February 1, 2018

   · 

  3 min read
• Deals

  Medicure Announces Receipt of Deferred Proceeds from Apicore Sale

  Medicure today announced that it has received the deferred purchase price proceeds of approximately US$50 million from the sale of its interests in Apicore to an arm’s length, pharmaceutical company (the “Buyer”), a transaction that closed and was announced in October 2017.

  February 1, 2018

   · 

  4 min read
• Business

  INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors

  A former GE Healthcare finance executive and the current chief financial officer of Endologix, Inc., Mr. Mahboob will also serve on the board’s audit committee.

  February 1, 2018

   · 

  2 min read
• Policy

  Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina

  InEK, is responsible for prioritizing new therapies in Germany through the NUB process.

  February 1, 2018

   · 

  8 min read